Figure 30: Included volume and ligand occupation of the SH-053-2′F-S-CH3 17 and SH-053-2′F-R-CH3 2 enantiomers in the α5 and γ2 pharmacophore/receptor models. This figure was modified and reproduced from that reported by Clayton et al. in [22, 23].